Ophthalmic Therapeutics/Drug Market - Global Outlook and Forecast 2022-2028

January 2022 | 66 pages | ID: O30820F6295CEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Ophthalmic Therapeutics/Drug in Global, including the following market information:

Global Ophthalmic Therapeutics/Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Ophthalmic Therapeutics/Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Anti-allergy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Ophthalmic Therapeutics/Drug include Alcon, Johnson and Johnson Vision Care, Inc., Bausch & Lomb Incorporated, Novartis AG, Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals Inc., Allergan, Pfizer Inc. and Valeant, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ophthalmic Therapeutics/Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Ophthalmic Therapeutics/Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Ophthalmic Therapeutics/Drug Market Segment Percentages, by Type, 2021 (%)

• Anti-allergy
• Anti-VEGF Agents
• Anti-inflammatory
• Anti-glaucoma
• Others

Global Ophthalmic Therapeutics/Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Ophthalmic Therapeutics/Drug Market Segment Percentages, by Application, 2021 (%)

• Dry Eye
• Allergies
• Glaucoma
• Infection
• Retinal Disorders
• Uveitis
• Others

Global Ophthalmic Therapeutics/Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Ophthalmic Therapeutics/Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Ophthalmic Therapeutics/Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Ophthalmic Therapeutics/Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Alcon
• Johnson and Johnson Vision Care, Inc.
• Bausch & Lomb Incorporated
• Novartis AG
• Merck Sharp & Dohme Corp.
• Regeneron Pharmaceuticals Inc.
• Allergan
• Pfizer Inc.
• Valeant
• Bayer AG
• Santen Pharmaceuticals Co. Ltd
• Genentech, Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Ophthalmic Therapeutics/Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Ophthalmic Therapeutics/Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OPHTHALMIC THERAPEUTICS/DRUG OVERALL MARKET SIZE

2.1 Global Ophthalmic Therapeutics/Drug Market Size: 2021 VS 2028
2.2 Global Ophthalmic Therapeutics/Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Ophthalmic Therapeutics/Drug Players in Global Market
3.2 Top Global Ophthalmic Therapeutics/Drug Companies Ranked by Revenue
3.3 Global Ophthalmic Therapeutics/Drug Revenue by Companies
3.4 Top 3 and Top 5 Ophthalmic Therapeutics/Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Ophthalmic Therapeutics/Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ophthalmic Therapeutics/Drug Players in Global Market
  3.6.1 List of Global Tier 1 Ophthalmic Therapeutics/Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Ophthalmic Therapeutics/Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Ophthalmic Therapeutics/Drug Market Size Markets, 2021 & 2028
  4.1.2 Anti-allergy
  4.1.3 Anti-VEGF Agents
  4.1.4 Anti-inflammatory
  4.1.5 Anti-glaucoma
  4.1.6 Others
4.2 By Type - Global Ophthalmic Therapeutics/Drug Revenue & Forecasts
  4.2.1 By Type - Global Ophthalmic Therapeutics/Drug Revenue, 2017-2022
  4.2.2 By Type - Global Ophthalmic Therapeutics/Drug Revenue, 2023-2028
  4.2.3 By Type - Global Ophthalmic Therapeutics/Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Ophthalmic Therapeutics/Drug Market Size, 2021 & 2028
  5.1.2 Dry Eye
  5.1.3 Allergies
  5.1.4 Glaucoma
  5.1.5 Infection
  5.1.6 Retinal Disorders
  5.1.7 Uveitis
  5.1.8 Others
5.2 By Application - Global Ophthalmic Therapeutics/Drug Revenue & Forecasts
  5.2.1 By Application - Global Ophthalmic Therapeutics/Drug Revenue, 2017-2022
  5.2.2 By Application - Global Ophthalmic Therapeutics/Drug Revenue, 2023-2028
  5.2.3 By Application - Global Ophthalmic Therapeutics/Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Ophthalmic Therapeutics/Drug Market Size, 2021 & 2028
6.2 By Region - Global Ophthalmic Therapeutics/Drug Revenue & Forecasts
  6.2.1 By Region - Global Ophthalmic Therapeutics/Drug Revenue, 2017-2022
  6.2.2 By Region - Global Ophthalmic Therapeutics/Drug Revenue, 2023-2028
  6.2.3 By Region - Global Ophthalmic Therapeutics/Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Ophthalmic Therapeutics/Drug Revenue, 2017-2028
  6.3.2 US Ophthalmic Therapeutics/Drug Market Size, 2017-2028
  6.3.3 Canada Ophthalmic Therapeutics/Drug Market Size, 2017-2028
  6.3.4 Mexico Ophthalmic Therapeutics/Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Ophthalmic Therapeutics/Drug Revenue, 2017-2028
  6.4.2 Germany Ophthalmic Therapeutics/Drug Market Size, 2017-2028
  6.4.3 France Ophthalmic Therapeutics/Drug Market Size, 2017-2028
  6.4.4 U.K. Ophthalmic Therapeutics/Drug Market Size, 2017-2028
  6.4.5 Italy Ophthalmic Therapeutics/Drug Market Size, 2017-2028
  6.4.6 Russia Ophthalmic Therapeutics/Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Ophthalmic Therapeutics/Drug Market Size, 2017-2028
  6.4.8 Benelux Ophthalmic Therapeutics/Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Ophthalmic Therapeutics/Drug Revenue, 2017-2028
  6.5.2 China Ophthalmic Therapeutics/Drug Market Size, 2017-2028
  6.5.3 Japan Ophthalmic Therapeutics/Drug Market Size, 2017-2028
  6.5.4 South Korea Ophthalmic Therapeutics/Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Ophthalmic Therapeutics/Drug Market Size, 2017-2028
  6.5.6 India Ophthalmic Therapeutics/Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Ophthalmic Therapeutics/Drug Revenue, 2017-2028
  6.6.2 Brazil Ophthalmic Therapeutics/Drug Market Size, 2017-2028
  6.6.3 Argentina Ophthalmic Therapeutics/Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Ophthalmic Therapeutics/Drug Revenue, 2017-2028
  6.7.2 Turkey Ophthalmic Therapeutics/Drug Market Size, 2017-2028
  6.7.3 Israel Ophthalmic Therapeutics/Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Ophthalmic Therapeutics/Drug Market Size, 2017-2028
  6.7.5 UAE Ophthalmic Therapeutics/Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Alcon
  7.1.1 Alcon Corporate Summary
  7.1.2 Alcon Business Overview
  7.1.3 Alcon Ophthalmic Therapeutics/Drug Major Product Offerings
  7.1.4 Alcon Ophthalmic Therapeutics/Drug Revenue in Global Market (2017-2022)
  7.1.5 Alcon Key News
7.2 Johnson and Johnson Vision Care, Inc.
  7.2.1 Johnson and Johnson Vision Care, Inc. Corporate Summary
  7.2.2 Johnson and Johnson Vision Care, Inc. Business Overview
  7.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Major Product Offerings
  7.2.4 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Revenue in Global Market (2017-2022)
  7.2.5 Johnson and Johnson Vision Care, Inc. Key News
7.3 Bausch & Lomb Incorporated
  7.3.1 Bausch & Lomb Incorporated Corporate Summary
  7.3.2 Bausch & Lomb Incorporated Business Overview
  7.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Major Product Offerings
  7.3.4 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Revenue in Global Market (2017-2022)
  7.3.5 Bausch & Lomb Incorporated Key News
7.4 Novartis AG
  7.4.1 Novartis AG Corporate Summary
  7.4.2 Novartis AG Business Overview
  7.4.3 Novartis AG Ophthalmic Therapeutics/Drug Major Product Offerings
  7.4.4 Novartis AG Ophthalmic Therapeutics/Drug Revenue in Global Market (2017-2022)
  7.4.5 Novartis AG Key News
7.5 Merck Sharp & Dohme Corp.
  7.5.1 Merck Sharp & Dohme Corp. Corporate Summary
  7.5.2 Merck Sharp & Dohme Corp. Business Overview
  7.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Major Product Offerings
  7.5.4 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Revenue in Global Market (2017-2022)
  7.5.5 Merck Sharp & Dohme Corp. Key News
7.6 Regeneron Pharmaceuticals Inc.
  7.6.1 Regeneron Pharmaceuticals Inc. Corporate Summary
  7.6.2 Regeneron Pharmaceuticals Inc. Business Overview
  7.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Major Product Offerings
  7.6.4 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Revenue in Global Market (2017-2022)
  7.6.5 Regeneron Pharmaceuticals Inc. Key News
7.7 Allergan
  7.7.1 Allergan Corporate Summary
  7.7.2 Allergan Business Overview
  7.7.3 Allergan Ophthalmic Therapeutics/Drug Major Product Offerings
  7.7.4 Allergan Ophthalmic Therapeutics/Drug Revenue in Global Market (2017-2022)
  7.7.5 Allergan Key News
7.8 Pfizer Inc.
  7.8.1 Pfizer Inc. Corporate Summary
  7.8.2 Pfizer Inc. Business Overview
  7.8.3 Pfizer Inc. Ophthalmic Therapeutics/Drug Major Product Offerings
  7.8.4 Pfizer Inc. Ophthalmic Therapeutics/Drug Revenue in Global Market (2017-2022)
  7.8.5 Pfizer Inc. Key News
7.9 Valeant
  7.9.1 Valeant Corporate Summary
  7.9.2 Valeant Business Overview
  7.9.3 Valeant Ophthalmic Therapeutics/Drug Major Product Offerings
  7.9.4 Valeant Ophthalmic Therapeutics/Drug Revenue in Global Market (2017-2022)
  7.9.5 Valeant Key News
7.10 Bayer AG
  7.10.1 Bayer AG Corporate Summary
  7.10.2 Bayer AG Business Overview
  7.10.3 Bayer AG Ophthalmic Therapeutics/Drug Major Product Offerings
  7.10.4 Bayer AG Ophthalmic Therapeutics/Drug Revenue in Global Market (2017-2022)
  7.10.5 Bayer AG Key News
7.11 Santen Pharmaceuticals Co. Ltd
  7.11.1 Santen Pharmaceuticals Co. Ltd Corporate Summary
  7.11.2 Santen Pharmaceuticals Co. Ltd Business Overview
  7.11.3 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Major Product Offerings
  7.11.4 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Revenue in Global Market (2017-2022)
  7.11.5 Santen Pharmaceuticals Co. Ltd Key News
7.12 Genentech, Inc.
  7.12.1 Genentech, Inc. Corporate Summary
  7.12.2 Genentech, Inc. Business Overview
  7.12.3 Genentech, Inc. Ophthalmic Therapeutics/Drug Major Product Offerings
  7.12.4 Genentech, Inc. Ophthalmic Therapeutics/Drug Revenue in Global Market (2017-2022)
  7.12.5 Genentech, Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Ophthalmic Therapeutics/Drug Market Opportunities & Trends in Global Market
Table 2. Ophthalmic Therapeutics/Drug Market Drivers in Global Market
Table 3. Ophthalmic Therapeutics/Drug Market Restraints in Global Market
Table 4. Key Players of Ophthalmic Therapeutics/Drug in Global Market
Table 5. Top Ophthalmic Therapeutics/Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Ophthalmic Therapeutics/Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Ophthalmic Therapeutics/Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Ophthalmic Therapeutics/Drug Product Type
Table 9. List of Global Tier 1 Ophthalmic Therapeutics/Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ophthalmic Therapeutics/Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Ophthalmic Therapeutics/Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Ophthalmic Therapeutics/Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Ophthalmic Therapeutics/Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Ophthalmic Therapeutics/Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Ophthalmic Therapeutics/Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Ophthalmic Therapeutics/Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2023-2028
Table 30. Alcon Corporate Summary
Table 31. Alcon Ophthalmic Therapeutics/Drug Product Offerings
Table 32. Alcon Ophthalmic Therapeutics/Drug Revenue (US$, Mn), (2017-2022)
Table 33. Johnson and Johnson Vision Care, Inc. Corporate Summary
Table 34. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Product Offerings
Table 35. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Revenue (US$, Mn), (2017-2022)
Table 36. Bausch & Lomb Incorporated Corporate Summary
Table 37. Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Product Offerings
Table 38. Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Revenue (US$, Mn), (2017-2022)
Table 39. Novartis AG Corporate Summary
Table 40. Novartis AG Ophthalmic Therapeutics/Drug Product Offerings
Table 41. Novartis AG Ophthalmic Therapeutics/Drug Revenue (US$, Mn), (2017-2022)
Table 42. Merck Sharp & Dohme Corp. Corporate Summary
Table 43. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Product Offerings
Table 44. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Revenue (US$, Mn), (2017-2022)
Table 45. Regeneron Pharmaceuticals Inc. Corporate Summary
Table 46. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Product Offerings
Table 47. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Revenue (US$, Mn), (2017-2022)
Table 48. Allergan Corporate Summary
Table 49. Allergan Ophthalmic Therapeutics/Drug Product Offerings
Table 50. Allergan Ophthalmic Therapeutics/Drug Revenue (US$, Mn), (2017-2022)
Table 51. Pfizer Inc. Corporate Summary
Table 52. Pfizer Inc. Ophthalmic Therapeutics/Drug Product Offerings
Table 53. Pfizer Inc. Ophthalmic Therapeutics/Drug Revenue (US$, Mn), (2017-2022)
Table 54. Valeant Corporate Summary
Table 55. Valeant Ophthalmic Therapeutics/Drug Product Offerings
Table 56. Valeant Ophthalmic Therapeutics/Drug Revenue (US$, Mn), (2017-2022)
Table 57. Bayer AG Corporate Summary
Table 58. Bayer AG Ophthalmic Therapeutics/Drug Product Offerings
Table 59. Bayer AG Ophthalmic Therapeutics/Drug Revenue (US$, Mn), (2017-2022)
Table 60. Santen Pharmaceuticals Co. Ltd Corporate Summary
Table 61. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Product Offerings
Table 62. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Revenue (US$, Mn), (2017-2022)
Table 63. Genentech, Inc. Corporate Summary
Table 64. Genentech, Inc. Ophthalmic Therapeutics/Drug Product Offerings
Table 65. Genentech, Inc. Ophthalmic Therapeutics/Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Ophthalmic Therapeutics/Drug Segment by Type in 2021
Figure 2. Ophthalmic Therapeutics/Drug Segment by Application in 2021
Figure 3. Global Ophthalmic Therapeutics/Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Ophthalmic Therapeutics/Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Ophthalmic Therapeutics/Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ophthalmic Therapeutics/Drug Revenue in 2021
Figure 8. By Type - Global Ophthalmic Therapeutics/Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Ophthalmic Therapeutics/Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Ophthalmic Therapeutics/Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Ophthalmic Therapeutics/Drug Revenue Market Share, 2017-2028
Figure 12. US Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Ophthalmic Therapeutics/Drug Revenue Market Share, 2017-2028
Figure 16. Germany Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Ophthalmic Therapeutics/Drug Revenue Market Share, 2017-2028
Figure 24. China Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Ophthalmic Therapeutics/Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Ophthalmic Therapeutics/Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Ophthalmic Therapeutics/Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Alcon Ophthalmic Therapeutics/Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis AG Ophthalmic Therapeutics/Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Allergan Ophthalmic Therapeutics/Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pfizer Inc. Ophthalmic Therapeutics/Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Valeant Ophthalmic Therapeutics/Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Bayer AG Ophthalmic Therapeutics/Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Genentech, Inc. Ophthalmic Therapeutics/Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)